Lucinda Warren's Insider Trades & SAST Disclosures

Lucinda Warren's most recent trade in Cue Biopharma Inc was a trade of 250,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on March 21, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Cue Biopharma Inc
Lucinda Warren CHIEF BUSINESS OFFICER 21 Mar 2025 250,000 250,000 - - Stock Option (right to buy)
Cue Biopharma Inc
Lucinda Warren CHIEF BUSINESS OFFICER 03 Sep 2024 350,000 350,000 - - Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades